Back to mobile site

Teladoc (TDOC) Tops Q2 EPS by 6c, Revenue Misses, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. NVDA
10. BLZE

July 31, 2024 4:13 PM EDT

Teladoc (NYSE: TDOC) reported Q2 EPS of ($0.28), $0.06 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $642 million versus the consensus estimate of $649.49 million.

Financial Outlook

Teladoc Health is withdrawing the financial outlook for the Full Year of 2024 for its Consolidated operations and its BetterHelp segment that was last provided on April 25, 2024. It is also withdrawing its three year outlook on its Consolidated operations and its operating segments that had last been reaffirmed on April 25, 2024.

The outlook provided for the Integrated Care segment is based on current market conditions and expectations and what we know today. Accordingly, we believe our outlook ranges provide a reasonable baseline for future financial performance.

Integrated Care

For the third quarter of 2024, we expect
Revenue growth percentage (year-over-year)(1)% - 2%
Adjusted EBITDA margin14.5% - 16.0%
U.S. Integrated Care Members (2)92.5 - 93.5 million
For the full year of 2024, we expect
Revenue growth percentage (year-over-year)Low single digits to mid-single digits
Adjusted EBITDA margin expansion (year-over-year)+150bps to +200bps
U.S. Integrated Care Members (2)92.5 - 94.0 million

For earnings history and earnings-related data on Teladoc (TDOC) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK